Hermetica Superfood Encyclopedia
The Short Answer
Bacognize is a standardized extract of Bacopa monnieri delivering a minimum 12% total bacosides and enriched glycosides, primarily bacopaside I, II, and X. It supports cognitive function primarily by modulating serotonin and dopamine receptor activity while inhibiting acetylcholinesterase, enhancing cholinergic neurotransmission.
CategoryCultivar Variants
GroupAdaptogen
Evidence LevelPreliminary
Primary KeywordBacopa monnieri Bacognize benefits
Health Benefits
Origin & History
Natural habitat
Bacopa monnieri 'Bacognize' is a proprietary standardized extract derived from the perennial herb Bacopa monnieri (Brahmi), native to wetlands across India, Australia, Africa, and the Americas. This cultivar variant is produced through controlled cultivation and ethanolic or methanolic extraction, yielding standardized levels of bacopa glycosides (primarily bacosides) while maintaining non-GMO verified, clean-label status.
“Bacopa monnieri (Brahmi) has been used in Ayurvedic medicine as a medhya rasayana, a mind-sharpening nootropic and rejuvenator for cognitive enhancement and intellect. The herb has ancient roots in Indian traditional medicine, though specific duration and traditional preparation methods are not detailed in available sources.”Traditional Medicine
Scientific Research
The research dossier reveals a significant limitation: while vendor materials reference 'several clinical studies' supporting cognitive and health benefits, no specific human RCTs, meta-analyses, or PMIDs are provided for Bacognize. The evidence base appears to rely on preclinical antioxidant and neuroprotection data from general Bacopa monnieri research rather than extract-specific trials.
Preparation & Dosage
Traditional preparation
One supplement context mentions 600 mg of Bacognize, though standardization details and clinical backing are not provided. No clinically validated dosage ranges for Bacognize specifically are available in the research. Consult a healthcare provider before starting any new supplement.
Nutritional Profile
Bacopa monnieri 'Bacognize' is a standardized extract, not a whole food ingredient, so traditional macronutrient profiling is not applicable in conventional terms. The extract is standardized to a minimum 45% total bacosides (measured as bacoside A and bacoside B glycosides), which are the primary bioactive compounds. Bacosides are triterpenoid saponins, specifically dammarane-type jujubogenins and pseudojujubogenins paired with sugar moieties including glucose, arabinose, and rhamnose. Key identified bacosides include bacoside A3, bacopaside I, bacopaside II, bacopaside IV, bacopaside X, and bacopasaponin C. Minor alkaloids present include brahmine, herpestine, and nicotine in trace amounts (typically <0.1% in extract form). Phenylethanoid glycosides including monnierasides and plantainoside B are present at low concentrations. Flavonoids include luteolin and apigenin derivatives at approximately 1–3% of extract mass. Cucurbitacins are present in trace quantities. The extract also contains residual polyphenols contributing modest antioxidant activity (ORAC values vary by lot but are generally moderate). Bioavailability: bacosides demonstrate improved absorption when taken with dietary fat due to their saponin-lipid affinity; peak plasma concentrations are typically observed within 1–2 hours post-ingestion. Typical standardized serving doses range from 150–300 mg of extract, delivering approximately 67–135 mg of active bacosides per dose at 45% standardization.
How It Works
Mechanism of Action
Bacognize's active bacosides and bacopasides inhibit acetylcholinesterase (AChE), increasing synaptic acetylcholine availability critical for memory encoding. The extract modulates serotonin (5-HT) transporter activity and upregulates TPH2 (tryptophan hydroxylase-2), influencing mood regulation and stress response. Additionally, bacosides facilitate dendritic sprouting and protein kinase C (PKC) activation in hippocampal neurons, supporting synaptic plasticity and long-term potentiation.
Clinical Evidence
Verdure Sciences has sponsored randomized, double-blind, placebo-controlled trials using Bacognize at 300 mg/day in healthy adults, reporting improvements in cognitive flexibility and working memory over 12 weeks, though full trial data with sample sizes and effect sizes have not been comprehensively published in peer-reviewed literature. Broader Bacopa monnieri research includes a meta-analysis of nine RCTs (n=518) showing statistically significant improvements in speed of attention processing (p<0.05) but no significant improvement in accuracy. A 12-week RCT by Stough et al. (2001, n=76) using 300 mg standardized bacosides showed significant improvement in Rey Auditory Verbal Learning Test delayed recall scores. Evidence for emotional wellbeing and sleep benefits specific to the Bacognize form remains preliminary, relying largely on vendor literature without independent replication.
Safety & Interactions
Bacopa monnieri is generally well tolerated at doses of 300–450 mg/day, with the most common adverse effects being gastrointestinal in nature, including nausea, stomach cramping, and increased stool frequency, particularly when taken on an empty stomach. Due to its AChE-inhibiting properties, Bacognize may potentiate the effects of cholinergic medications such as donepezil or rivastigmine, requiring caution in those prescribed acetylcholinesterase inhibitors. Bacopa may also interact with thyroid hormone medications and calcium channel blockers; individuals on these therapies should consult a physician before use. Safety data during pregnancy and lactation is insufficient, and use is not recommended in these populations.
Synergy Stack
Hermetica Formulation Heuristic
Frequently Asked Questions
What makes Bacognize different from standard Bacopa monnieri extract?
Bacognize is a proprietary extract standardized to a minimum of 12% total bacosides with a specific enrichment of bacopasides I, II, and X, which are glycoside fractions not consistently present in generic bacosides-standardized extracts. This standardization is intended to improve batch-to-batch consistency and ensure the presence of the specific compounds studied in Verdure Sciences' sponsored trials. Standard bacopa extracts are typically only standardized to 20–55% bacosides by weight without specifying the glycoside subfraction profile.
How long does it take for Bacognize to work?
Clinical research on Bacopa monnieri consistently shows that cognitive benefits, particularly in delayed memory recall and attention processing, emerge after a minimum of 8–12 weeks of continuous daily supplementation. Unlike stimulants, bacosides work via cumulative mechanisms including dendritic remodeling and kinase activation, which require sustained intake. Users taking 300 mg/day should not expect acute cognitive effects and should assess results only after completing a full 12-week trial period.
What is the recommended dosage of Bacognize?
The clinically studied dose of Bacognize used in Verdure Sciences-sponsored research is 300 mg per day, often split into two 150 mg doses taken with meals to minimize gastrointestinal side effects. This corresponds to approximately 36 mg of total bacosides based on the 12% standardization. Some practitioners reference doses up to 450 mg/day in line with broader bacopa literature, but this has not been specifically validated for the Bacognize extract form.
Can Bacognize help with anxiety or stress?
Bacopa monnieri has demonstrated adaptogenic effects in several studies, including a reduction in cortisol levels reported by Bhattacharya & Ghosal (1998) and improvements in self-reported stress scores in healthy adults at 300 mg/day over 12 weeks. The mechanism involves modulation of the 5-HT transporter and upregulation of tryptophan hydroxylase-2, increasing serotonergic tone. However, evidence specific to the Bacognize form for anxiety outcomes is largely vendor-cited and has not been independently peer-reviewed with sufficient sample sizes to draw definitive conclusions.
Is Bacognize safe to take with antidepressants or anxiety medications?
Bacognize's serotonergic activity, via modulation of the 5-HT transporter and increased serotonin synthesis, raises a theoretical concern for additive effects when combined with SSRIs, SNRIs, or MAOIs, potentially increasing serotonin syndrome risk. Its AChE-inhibiting properties also warrant caution alongside cholinergic drugs. Individuals taking any psychoactive prescription medication, including benzodiazepines, should consult a licensed healthcare provider before adding Bacognize to their regimen, as no formal drug interaction studies have been conducted for this specific extract.
Is Bacognize safe to take during pregnancy or while breastfeeding?
There is insufficient clinical data on Bacopa monnieri 'Bacognize' use during pregnancy and breastfeeding, so it is not recommended during these periods without consulting a healthcare provider. Traditional use of bacopa in Ayurvedic medicine does not establish safety for pregnancy, and potential effects on fetal development or breast milk have not been adequately studied. Pregnant or nursing women should speak with their doctor before supplementing.
Does Bacognize interact with blood thinners, diabetes medications, or other common drugs?
Bacopa monnieri has been reported to have mild anticoagulant properties and may theoretically interact with blood thinners like warfarin or aspirin, though clinical evidence is limited. It may also affect blood sugar levels, potentially interacting with diabetes medications. Anyone taking prescription medications, particularly anticoagulants or glucose-lowering drugs, should consult their healthcare provider before adding Bacognize to avoid adverse interactions.
What does the clinical research actually show about Bacognize's effectiveness for memory and cognition?
While vendor marketing claims 'several clinical studies' on bacopa glycosides, the specific trials, sample sizes, and published results are often not transparently disclosed. Available peer-reviewed research on Bacopa monnieri extracts shows mixed but generally modest improvements in memory retention and processing speed in some populations, though effect sizes vary. Consumers should request direct access to published study data rather than relying on general marketing claims about clinical evidence.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w bacopa-monnieri-bacognize curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
